CAN04

· Cantargia AB

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAN04, covering 2023-07-03 to 2024-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors [Phase 1, Phase 2]